Abrocitinib scores wins for AD

Expert Name
Dr Ricardo Rojo Cella

Dr Ricardo Rojo Cella is Executive Director at Pfizer, where he has worked since 2009. He received his MD at the Universidad La Salle, Spain, after which he obtained a Master’s degree in Neuroscience from the Universitat de Barcelona, Spain.      The Phase 3 JADE REGIMEN study (NCT03627767) was a 52-week study investigated abrocitinib, an investigational oral once-daily Janus…

COVID-19 and Implications for Type 2 Inflammatory Diseases

Expert Name
Prof. Georg Schett

Prof. Georg Schett is Chair of Internal Medicine 3 –Rheumatology and Immunology– at Friedrich-Alexander Universität (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen in Germany. His scientific work focuses on creating a better understanding of the molecular basis of immune-inflammatory diseases with rapid translation into clinical practice. His research work lead to the understanding of the phenomenon of LE-cells in 2007. Prof. Schett…

Clinical assessment and management of different endotypes and phenotypes of severe asthma

Expert Name
Dr Liam Heaney

Dr Liam Heaney is a professor of respiratory medicine at Queen’s University Belfast (UK) and a consultant physician at Belfast City Hospital. He leads the Medical Research Council Refractory Stratification Programme (RASP-UK) to transform clinical management of severe asthma, produce more personalised treatment approaches and investigate novel treatment strategies. Prof. Heaney also founded the British Thoracic Society Difficult Asthma Network…

Holistic View on Asthma

Expert Name
Prof. Zuzana Diamant

In the past 15 years, striking progress has been made in our understanding of the mechanisms underlying chronic inflammatory airway disease as well as the predisposing and interfering factors. These insights have resulted in a more holistic and personalised approach to the diagnosis and management of chronic inflammatory airway diseases including their comorbidities. At the annual congress of the European…